West Pharmaceutical Services, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a WST research report →
About the company
West Pharmaceutical Services, Inc. (WST) specializes in the development, manufacturing, and global distribution of essential containment and delivery solutions for injectable pharmaceuticals and other healthcare products. The company's operations span across the Americas, Europe, the Middle East, Africa, and the Asia Pacific region, structured into two primary business units: Proprietary Products and Contract-Manufactured Products.
- CEO
- Eric Green
- IPO
- 1980
- Employees
- 10,600
- HQ
- Exton, PA, US
Price Chart
- Market Cap
- $25.84B
- P/E
- 48.64
- P/S
- 8.02
- P/B
- 8.81
- EV/EBITDA
- 30.39
- Div Yield
- 0.24%
- Gross Margin
- 36.24%
- Op Margin
- 20.67%
- Net Margin
- 16.85%
- ROE
- 17.87%
- ROIC
- 15.24%
- Revenue
- $3.07B · 6.26%
- Net Income
- $493.70M · 0.20%
- EPS
- $6.83 · 1.19%
- Op Income
- $617.40M
- FCF YoY
- 69.65%
- 52W High
- $367.66
- 52W Low
- $206.80
- 50D MA
- $319.81
- 200D MA
- $275.98
- Beta
- 1.16
- Avg Volume
- 850.08K
Get TickerSpark's AI analysis on WST
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jun 30, 26 | HAUGEN JANET BRUTSCHEA | other | 46 |
| May 12, 26 | Campbell Shane Alden | other | 473.593 |
| May 12, 26 | Campbell Shane Alden | other | 295.995 |
| May 12, 26 | Campbell Shane Alden | other | 473.593 |
| May 12, 26 | Campbell Shane Alden | other | 134.927 |
| May 12, 26 | Campbell Shane Alden | other | 295.995 |
| May 12, 26 | Campbell Shane Alden | other | 84.329 |
| May 4, 26 | Pucci Paolo | other | 791 |
| May 4, 26 | Michels Douglas A | other | 791 |
| May 4, 26 | Lockhart Stephen H | other | 791 |
Our WST coverage
Recent articles, reports, and earnings notes.
No research on WST yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate WST report →Similar companies
Peers in the same neighborhood.